Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Merck KGaA presents novel factor Xa and factor VIIa inhibitors

Oct. 21, 2004

Novel prostanoid DP antagonists under study at Taisho

Oct. 21, 2004

New TARC and MDC regulators prepared and tested at Kyowa Hakko

Oct. 21, 2004

Kyorin patent covers novel S1P receptor ligands and their use

Oct. 21, 2004

Roche researchers identify new uPA antagonists for use in cancer therapy

Oct. 21, 2004

Merck scientists present new nonsteroidal glucocorticoid receptor modulators

Oct. 21, 2004

Novel kappa opioid agonists developed at SSP

Oct. 21, 2004

New photosensitizer isolated from plant extract by AIST scientists

Oct. 21, 2004

Provid scientists present new MHC binding modulators for multiple sclerosis and other disorders

Oct. 20, 2004

GSK patent covers new anti-HCV NS5B inhibitors

Oct. 20, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...